Astrazeneca has been
granted an injunction in the USA
which restrains Actavis from
further distribution of its generic
version of Pulmicort Respules
(budesonide), pending resolution
of an appeal against a ruling by a
US district court that the Actavis
version did not infringe patents.The above article was sent to subscribers in Pharmacy Daily's issue from 27 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 13
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.